A detailed history of Woodline Partners LP transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 301,224 shares of TERN stock, worth $1.77 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
301,224
Previous 745,044 59.57%
Holding current value
$1.77 Million
Previous $5.07 Million 50.48%
% of portfolio
0.02%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.49 - $10.8 $2.88 Million - $4.79 Million
-443,820 Reduced 59.57%
301,224 $2.51 Million
Q2 2024

Aug 14, 2024

BUY
$4.54 - $8.2 $3.38 Million - $6.11 Million
745,044 New
745,044 $5.07 Million

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.